Status:
RECRUITING
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Gynecologic Cancer
Hereditary Cancer Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual...
Eligibility Criteria
Inclusion Criteria:
- 8 years of age or older.
- Scheduled for a New Patient appointment in the gynecology clinic. Speaks and reads in English.
- Access to a telephone with texting capacity.
- Has not had prior genetic testing for hereditary cancer syndromes.
Exclusion Criteria:
- Under 18 years of age
- Has had previous genetic testing for hereditary cancer syndromes
- Does not read/speak in English
- Does not have access to a phone with texting capabilities
Key Trial Info
Start Date :
January 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05562778
Start Date
January 15 2023
End Date
December 1 2026
Last Update
July 28 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
NYP Brooklyn Methodist Hospital
Brooklyn, New York, United States, 11215
2
NYP Lower Manhattan Hospital
New York, New York, United States, 10038
3
Weill Cornell Medicine
New York, New York, United States, 10065
4
NYP Medical Group Queens
Queens, New York, United States, 11375